Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | RXRB | P28702 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | KHK | P50053 | 1/20 | 0.31 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2609891 | 0.98 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL14685282 | 0.96 | L3MBTL1 (0.40) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL2609886 | 0.96 | L3MBTL1 (0.41) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL2609888 | 0.95 | L3MBTL1 (0.39) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL2609901 | 0.95 | KDM4E (0.39) | KDM4EATML3MBTL1HDAC4DUSP3 | |
| SCHEMBL2609864 | 0.94 | L3MBTL1 (0.38) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL2609882 | 0.94 | KDM4E (0.41) | KDM4EATML3MBTL1HDAC4DUSP3 | |
| SCHEMBL2609879 | 0.93 | KDM4E (0.37) | KDM4EATML3MBTL1HDAC4RXRA | |
| SCHEMBL2609887 | 0.93 | KDM4E (0.39) | KDM4EATML3MBTL1HDAC4DUSP3 | |
| SCHEMBL2609894 | 0.92 | KDM4E (0.38) | KDM4EATML3MBTL1HDAC4RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9224961-B2 | Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-29 | — | — | US | disclosed |
| US-9224961-B2 | Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode | SAMSUNG DISPLAY CO., LTD. (KR) | 2015-12-29 | — | — | US | disclosed |
| US-20120097932-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
| US-20120097932-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120097932-A1 | CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE | OCIAD1, OCIAD2, CFD | KDM4E 3315/4885ATM 4310/4885L3MBTL1 2477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.